Lower prostate cancer rates in obese men may not equal lower risk

09/14/2010 | Reuters

Data from government health surveys showed that obese men who underwent prostate cancer screening with a prostate-specific antigen blood test generally had lower PSA levels than their normal-weight counterparts. And overweight men who had a PSA screening were less likely to undergo a biopsy to confirm or rule out cancer. The findings indicate that the lower rates of disease occurrence among the group may be due to a lower percentage of early detection.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA